France Autoimmune Disease Diagnostics Market Insight
Published: 06 June 2026 | Report Format: Electronic (PDF)
The France Autoimmune Disease Diagnostics Market will grow at a rate of 8.7% due to Rising Prevalence of Autoimmune Disorders, Technological Advancements, Focus on Early Detection and Precision Medicine, Supportive Healthcare Infrastructure.
France Autoimmune Disease Diagnostics Market Insights Forecasts to 2035
- The France Autoimmune Disease Diagnostics Market Size Was Estimated USD 478 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.7% from 2025 to 2035
- The France Autoimmune Disease Diagnostics Market Size is Expected to rise around USD USD 1.10 Billion by 2035
Notable Insights for the France Autoimmune Disease Diagnostics Market
- Segmentation on the basis of technology indicates that due to the widespread use of first-line autoantibody testing, the immunoassays category will account for between 31% and 35% of the French autoimmune disease diagnostics market in 2025.
- Segmentation on the basis of Application indicates that due to ageing populations and the requirement for continuous illness monitoring, the rheumatoid arthritis segment will account for between 32% and 37% of the French autoimmune disease diagnostics market in 2025.
- France is accelerating autoimmune diagnostics through the ATRACTion program, a €9.9 million initiative uniting 11 healthcare partners to leverage AI and multi-omics for precision diagnostics and therapeutics.
- France’s RIHN 2.0 pathway supports innovative autoimmune diagnostics with access to €521.5 million funding in 2024, enabling clinical validation, evidence generation, and accelerated reimbursement approval.
Download the eBook (ToC)
Why Buy This Report
- This report will present in-depth analysis of market size, growth projections, competitive environment, and new technology development within this field to assist stakeholders in pinpointing high growth opportunities and determining investment priorities.
- Market segmentation based on technology, disease type and end user will also be analyzed to allow for a detailed understanding of customer buying trends, preferences and profit driven segments of the market.
- Analysis of the impact of regulatory changes, reimbursement scenarios, and innovation strategies coupled with key industry trends in France will be detailed to aid companies in strategic market planning, new market entry and market expansion efforts.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Autoimmune Disease Diagnostics Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Autoimmune Disease Diagnostics Market
- Roche
- bioMérieux
- Bio-Rad Laboratories
- Abbott Laboratories
- Thermo Fisher Scientific
- Siemens Healthineers
- Danaher Corporation
- Inova Diagnostics (Werfen)
- Euroimmun
- Myriad Genetics
Recent Developments:
- In October 2025, Sanofi, Immun4Cure, INSERM, CHU Montpellier, and the University of Montpellier launched a 5-year Translational Center of Excellence dedicated to autoimmune and inflammatory diseases, creating a world-first platform to accelerate biomarker discovery, precision diagnostics, and therapeutic development.
- In April 2025, EUROIMMUN launched 23 new assays for its UNIQO 160 automated platform, including 7 new tests for autoimmune neurological diseases, enhancing laboratory throughput with processing capacity of 160 samples per run.
Market Segmentation:
France Autoimmune Disease Diagnostics Market, By Technology
- Immunoassays
- Molecular Diagnostics
- Imaging Techniques
- Biopsy
- Histopathology
- Others
France Autoimmune Disease Diagnostics Market, By Application
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Multiple Sclerosis
- Type 1 Diabetes
- Other Autoimmune Diseases
France Autoimmune Disease Diagnostics Market, By End User
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Point-of-Care Centers
- Others
Expert Views:
The France autoimmune diseases diagnostics market is expected to grow steadily till 2035 owing to increase in number of cases of autoimmune diseases across France, rise in implementation of immunoassay and molecular diagnostics, increase in importance for diagnosis and precision medicine. The supportive government schemes, increased investment in innovation and technology and AI based diagnostics, and tie-ups of eminent healthcare organizations are likely to increase diagnostic accuracy, boost patient prognosis and provide market opportunities to market players.
Author: Sanket and Pranali By Spherical Insights and Consulting